Valvulo-Arterial Impedance in Patients with Severe Aortic Stenosis and Bicuspid Aortic Valve
Journal of Cardiovascular Development and Disease · 09.04.2026 · 13 (4) · 163
DOI: 10.3390/jcdd13040163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 09.04.2026. Verfasst von Chun Kit Ng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Risk stratification in patients with bicuspid aortic valve (BAV) and severe aortic stenosis (AS) remains challenging. Valvulo-arterial impedance (Zva), an integrated marker of global left ventricular (LV) afterload, has shown prognostic value in tricuspid AS; however, data in BAV are limited. This study aimed to evaluate the association of Zva with LV remodeling, symptoms, and all-cause death in patients with BAV and severe AS.
Methods
In this retrospective, two-center cohort study, 147 patients with severe AS and BAV were included. Zva was calculated at the time of the first echocardiographic diagnosis of severe AS. The study endpoint was all-cause mortality.
Results
Over a median follow-up of 9.8 years, 24 patients (16%) died. A Zva threshold of 5 mmHg/mL/m2 was identified as optimal by ROC analysis. Patients with Zva ≥ 5 mmHg/mL/m2 showed higher mortality rates (29% vs. 10%; p = 0.003), more advanced symptoms (NYHA III-IV: 41% vs. 9%; p < 0.001), adverse LV remodeling, lower LVEF (60% (IQR 36–66) vs. 66% (IQR 61–71); p = 0.001), and worse LV global longitudinal strain (14.8% ± 2.7 vs. 16.5% ± 3.0; p = 0.016). Zva ≥ 5 mmHg/mL/m2 was independently associated with worse long-term survival after adjustment (HR 2.885; 95% CI 1.119–7.438; p = 0.028).
Conclusions
Among patients with BAV and severe AS, an increased Zva was associated with more advanced symptoms, adverse LV remodeling, impaired LV systolic function, and worse long-term survival, and might therefore help in risk stratification of these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.
- Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, G1V 4G5 Québec, QC, Canada.
- Department of Cardiology, Turku Heart Center, University of Turku and Turku University Hospital, 20520 Turku, Finland.
ORCID-Profile: Chun Kit Ng, Pilar Lopez Santi, Nadeem Elmasry, Steele C Butcher, Marie-Annick Clavel, Philippe Pibarot, Nina Ajmone Marsan
Zitieren
APA
Ng, C. K., Lopez Santi, P., Fleury, M. A., He, J., Elmasry, N., Butcher, S. C., Clavel, M. A., Pibarot, P., Bax, J. J., & Ajmone Marsan, N. (2026). Valvulo-Arterial Impedance in Patients with Severe Aortic Stenosis and Bicuspid Aortic Valve. Journal of Cardiovascular Development and Disease, 13(4), 163. https://doi.org/10.3390/jcdd13040163
Vancouver
Ng CK, Lopez Santi P, Fleury MA, He J, Elmasry N, Butcher SC, et al. Valvulo-Arterial Impedance in Patients with Severe Aortic Stenosis and Bicuspid Aortic Valve. Journal of Cardiovascular Development and Disease. 2026;13(4):163. doi:10.3390/jcdd13040163
BibTeX
@article{Ng2026,
author = {Ng, Chun Kit and Lopez Santi, Pilar and Fleury, Marie-Ange and He, Jingjing and Elmasry, Nadeem and Butcher, Steele C and Clavel, Marie-Annick and Pibarot, Philippe and Bax, Jeroen J and Ajmone Marsan, Nina},
title = {Valvulo-Arterial Impedance in Patients with Severe Aortic Stenosis and Bicuspid Aortic Valve},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {4},
pages = {163},
doi = {10.3390/jcdd13040163}
}
EUVIMED